Kensey Nash

IntraLuminal Therapeutics, Inc. is a medical device company focused on both providing and developing products for the Interventional Cardiologist and Radiologist to cross and recanalize totally occluded arteries.
The company was co-founded by Dr. Geoffrey Hartzler, pioneer of multi-vessel percutaneous transluminal coronary intervention (PTCI) and a recognized leader in the area of interventional cardiology. Incorporated in October 1997, the company is located in Carlsbad, California.

Contact Details: 735 Pennsylvania Drive Exton Pennsylvania 19341 United States of America Tel: (484) 713-2100 Fax: (484) 713-2900 Email: Safecrossquestions@kenseynash.com WWW: www.intraluminal.com/

Loading...

Recent Publications by Kensey Nash:
Effects of Whole Blood Viscosity on Atherogenesis. There is a high correlation between high whole blood viscosity and the...	14th April, 2000	Kensey Nash Corporation, 55 East Uwchlan Avenue, Suite 204, Exton, PA,	J Invasive Cardiol. 1997 Jan;9(1):17-24.
The Angio-Seal hemostatic puncture closure device. Concept and experimental results. The Angio-Seal hemostatic puncture closure device is the culmination of...	26th February, 2000	Kensey Nash Corporation (KNC), Exton, Pennsylvania, USA.	Herz. 1999 Dec;24(8):597-606.

BioNews Results for Kensey Nash:
Orthovita to Present at the Rodman & Renshaw 10th Annual Healthcare Conference	Genetic Engineering News:  Nov 5 2008 2:57AM Matching: kensey nash
Orthovita Reports 2008 Third Quarter Financial Results	Genetic Engineering News:  Nov 4 2008 12:17AM Matching: kensey nash
Orthovita to Present at the Rodman & Renshaw 10th Annual Healthcare Conference	Genetic Engineering News:  Nov 4 2008 11:20PM Matching: kensey nash
Orthovita Reports 2008 Third Quarter Financial Results	DiGiTAL50:  Nov 4 2008 8:52AM Matching: kensey nash
Orthovita Reports 2008 Third Quarter Financial Results	Genetic Engineering News:  Nov 3 2008 11:14PM Matching: kensey nash
Promote your company here: BioNewsCast - Press Release Distribution	→View more Kensey Nash news.

Kensey Nash Patents:
US Patent No.	Title
5938672	System and method of use for revascularizing stenotic bypass grafts and other blood vessels
6203556	Transmyocardial revascularization system and method of use
6264701	Device and methods for in vivo culturing of diverse tissue cells
6350280	Surgical connector systems and methods of use
6402767	Anastomosis connection system and method of use
→View more Kensey Nash patents.

Kensey Nash (KNSY) Financial information Links from Barchart
KNSY Quote from from Barchart.com
KNSY Chart from from Barchart.com
KNSY Profile from from Barchart.com
KNSY Opinion from from Barchart.com
→View more Kensey Nash finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 201 times since April 2007, the link to the organisation's website has been followed 31 times

Recent Search Terms used to find this page: angio seal patent knc | kensey nash jobs | kensey nash pharmacetical | Safecrossquestionskenseynash.com | Safecrossquestionskenseynash.com | .

Search for more companies in Exton

Search for more companies in Pennsylvania

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Kensey Nash